Virbac: 9m sales up 14.5%

(CercleFinance.com) - Animal health company Virbac has announced 9m 2021 sales of 817.
7 million euros (to end-September), up 19.3% excluding Sentinel (+14.5% on an actual basis).

Excluding negative FX factors, sales rose by 21.2% excluding Sentinel (+16.4% on an actual basis).

Virbac expects like-for-like sales growth (excluding the impact of the disposal of Sentinel) of between 16% and 18%, along with an operating profit before amortisation of assets acquired through acquisitions ratio of around 16% at constant exchange rates.


Copyright (c) 2021 CercleFinance.com. All rights reserved.